Phase II study of amrubicin and carboplatin in patients with the refractory or relapsed small cell lung cancer (SCLC).

被引：2
|
作者：
Hirose, T. [1 ]
Shirai, T. [1 ]
Kusumoto, S. [1 ]
Sugiyama, T. [1 ]
Yamaoka, T. [1 ]
Okuda, K. [1 ]
Ohmori, T. [1 ]
Ohnishi, T. [1 ]
Adachi, M. [1 ]
机构：
[1] Showa Univ, Sch Med, Tokyo 142, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.7057
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7057
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Carboplatin-etoposide in elderly small cell lung cancer (SCLC) patients: A phase II study
    Larive, S
    Bombaron, P
    ANNALS OF ONCOLOGY, 1998, 9 : 105 - 105
  • [22] A phase I study of amrubicin (AMR) and irinotecan (CPT-11) in relapsed small cell lung cancer(SCLC)
    Kawahara, M.
    Kubo, A.
    Komuta, K.
    Fukushima, M.
    Daimon, T.
    Furuse, K.
    Mio, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [23] A PHASE II STUDY OF AMRUBICIN AND CARBOPLATIN FOR PREVIOUSLY UNTREATED PATIENTS WITH EXTENSIVE-DISEASE SMALL CELL LUNG CANCER
    Kinoshita, Akitoshi
    Tomonaga, Nanae
    Saijo, Tomoyuki
    Ikeda, Takaya
    Fukuda, Minoru
    Nakamura, Yoichi
    Senju, Hiroaki
    Nakano, Hirofumi
    Kitazaki, Takeshi
    Ogawara, Daiki
    Taniguchi, Hirokazu
    Motoshima, Kohei
    Yamaguchi, Hiroyuki
    Nakatomi, Katsumi
    Shimada, Midori
    Nagashima, Seiji
    Tsukamoto, Kazuhiro
    Kohno, Shigeru
    RESPIROLOGY, 2014, 19 : 155 - 155
  • [24] A phase II study of amrubicin and carboplatin for previously untreated patients with extensive-disease small cell lung cancer
    Takaya Ikeda
    Minoru Fukuda
    Yoichi Nakamura
    Akitoshi Kinoshita
    Hiroaki Senju
    Hirofumi Nakano
    Takeshi Kitazaki
    Daiki Ogawara
    Hirokazu Taniguchi
    Kohei Motoshima
    Hiroyuki Yamaguchi
    Katsumi Nakatomi
    Midori Shimada
    Seiji Nagashima
    Kazuhiro Tsukamoto
    Shigeru Kohno
    Cancer Chemotherapy and Pharmacology, 2014, 74 : 497 - 502
  • [25] Phase II study of topotecan in refractory and sensitive small cell lung cancer (SCLC)
    Ardizzoni, A
    Hansen, HH
    Dombernowsky, P
    Kaplan, S
    Postmus, PE
    Gamucci, T
    Schaefer, B
    Wanders, J
    Verweij, J
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 84 - 84
  • [26] A phase II study of amrubicin and carboplatin for previously untreated patients with extensive-disease small cell lung cancer
    Ikeda, Takaya
    Fukuda, Minoru
    Nakamura, Yoichi
    Kinoshita, Akitoshi
    Senju, Hiroaki
    Nakano, Hirofumi
    Kitazaki, Takeshi
    Ogawara, Daiki
    Taniguchi, Hirokazu
    Motoshima, Kohei
    Yamaguchi, Hiroyuki
    Nakatomi, Katsumi
    Shimada, Midori
    Nagashima, Seiji
    Tsukamoto, Kazuhiro
    Kohno, Shigeru
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 74 (03) : 497 - 502
  • [27] A PHASE II STUDY OF AMRUBICIN AND CARBOPLATIN FOR PREVIOUSLY UNTREATED PATIENTS WITH EXTENSIVE-DISEASE SMALL CELL LUNG CANCER
    Ikeda, Takaya
    Taniguchi, Hirokazu
    Soda, Hiroshi
    Fukuda, Minoru
    Kinoshita, Akihito
    Fukuda, Masaaki
    Soejima, Yoshifumi
    Ogawara, Daiki
    Nakamura, Yoichi
    Kohno, Shigeru
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1157 - S1157
  • [28] Phase II study of amrubicin, a new active drug in refractory or relapsed small-cell lung cancer (SCLC): Thoracic Oncology Research Group Trial 0301.
    Seto, T.
    Masuda, N.
    Takiguchi, Y.
    Isobe, H.
    Okamoto, H.
    Ogura, T.
    Yokoyama, A.
    Watanabe, K.
    Eguchi, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 379S - 379S
  • [29] Paclitaxel in combination with carboplatin as salvage treatment in refractory small-cell lung cancer (SCLC): A multicenter phase II study
    Kakolyris, S
    Mavroudis, D
    Tsavaris, N
    Souglakos, J
    Tsiafaki, P
    Kalbakis, K
    Agelaki, S
    Androulakis, N
    Georgoulias, V
    ANNALS OF ONCOLOGY, 2001, 12 (02) : 193 - 197
  • [30] A phase II trial of combination chemotherapy with topotecan and amrubicin in small cell lung cancer (SCLC).
    Nogami, N.
    Kiura, K.
    Takigawa, N.
    Harita, S.
    Chikamori, K.
    Shibayama, T.
    Tabata, M.
    Hotta, K.
    Shinkai, T.
    Tanimoto, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345